| Breakdown | Dec 2025 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.70B | 21.91B | 20.28B | 15.54B | 10.19B |
| Gross Profit | 5.28B | 4.91B | 5.45B | 3.63B | 2.39B |
| EBITDA | 2.69B | 1.30B | 2.94B | 2.35B | 1.81B |
| Net Income | 1.73B | 1.10B | 1.93B | 1.66B | 1.26B |
Balance Sheet | |||||
| Total Assets | 44.94B | 40.93B | 34.96B | 24.95B | 20.79B |
| Cash, Cash Equivalents and Short-Term Investments | 9.36B | 7.73B | 5.40B | 4.78B | 5.03B |
| Total Debt | 11.26B | 10.02B | 7.94B | 3.65B | 3.45B |
| Total Liabilities | 30.34B | 28.75B | 23.42B | 14.85B | 12.00B |
| Stockholders Equity | 13.20B | 12.22B | 11.59B | 10.04B | 8.70B |
Cash Flow | |||||
| Free Cash Flow | 1.18B | 1.40B | 36.79M | -233.92M | -16.43M |
| Operating Cash Flow | 2.46B | 2.15B | 2.52B | 1.08B | 922.80M |
| Investing Cash Flow | -1.63B | -973.45M | -4.97B | 639.25M | -296.01M |
| Financing Cash Flow | -28.33M | 894.53M | 2.96B | -376.81M | -226.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$13.87B | 8.98 | 11.57% | 4.26% | 9.84% | 27.75% | |
75 Outperform | HK$14.67B | 3.69 | 10.76% | 4.49% | -4.80% | 2.58% | |
66 Neutral | HK$102.93B | 4.80 | 14.20% | 4.77% | 15.34% | 20.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$36.32B | 13.19 | 13.75% | 3.41% | 11.08% | 59.37% | |
57 Neutral | HK$73.50B | 19.02 | 7.49% | 7.28% | 14.66% | 30.39% | |
39 Underperform | HK$1.06B | -5.14 | -10.95% | ― | -10.77% | -25.12% |